Por favor, use este identificador para citar o enlazar este ítem: http://www.dspace.uce.edu.ec/handle/25000/15125
Título : Epigenetics in turner syndrome
Autor : Alvarez Nava, Francisco José
Lanes, Roberto
Palabras clave : ANEUPLOIDÍA
CROMATINA
METILACIÓN DEL ADN
CÉLULAS MADRE EMBRIONARIAS
EPIGENÉTICA
EXPRESIÓN GÉNICA
Fecha de publicación : 2018
Editorial : Quito: BioMed Central
Citación : Alvarez Nava, Francisco y Lanes, Roberto (2018). Epigenetics in turner syndrome. Clinical Epigenetics: 10-45
Resumen : Background: Monosomy of the X chromosome is the most frequent genetic abnormality in human as it is present in approximately 2% of all conceptions, although 99% of these embryos are spontaneously miscarried. In postnatal life, clinical features of Turner syndrome may include typical dysmorphic stigmata, short stature, sexual infantilism, and renal, cardiac, skeletal, endocrine and metabolic abnormalities. Main text: Turner syndrome is due to a partial or total loss of the second sexual chromosome, resulting in the development of highly variable clinical features. This phenotype may not merely be due to genomic imbalance from deleted genes but may also result from additive influences on associated genes within a given gene network, with an altered regulation of gene expression triggered by the absence of the second sex chromosome. Current studies in human and mouse models have demonstrated that this chromosomal abnormality leads to epigenetic changes, including differential DNA methylation in specific groups of downstream target genes in pathways associated with several clinical and metabolic features, mostly on autosomal chromosomes. In this article, we begin exploring the potential involvement of both genetic and epigenetic factors in the origin of X chromosome monosomy. We review the dispute between the meiotic and post-zygotic origins of 45,X monosomy, by mainly analyzing the findings from several studies that compare gene expression of the 45,X monosomy to their euploid and/or 47,XXX trisomic cell counterparts on peripheral blood mononuclear cells, amniotic fluid, human fibroblast cells, and induced pluripotent human cell lines. From these studies, a profile of epigenetic changes seems to emerge in response to chromosomal imbalance. An interesting finding of all these studies is that methylation-based and expression-based pathway analyses are complementary, rather than overlapping, and are correlated with the clinical picture displayed by TS subjects. Conclusions: The clarification of these possible causal pathways may have future implications in increasing the life expectancy of these patients and may provide informative targets for early pharmaceutical intervention.
URI : http://www.dspace.uce.edu.ec/handle/25000/15125
Aparece en las colecciones: Artículos Indexados

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Epigenetics in Turner syndrome.pdfARTÍCULO A TEXTO COMPLETO868.7 kBAdobe PDFVisualizar/Abrir


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.